Getinge AB (publ) (GNGBY) News Today $15.83 +0.14 (+0.89%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Headlines Stock AnalysisChartDividendEarningsHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Getinge AB: Why We Think There's Confusion Of Frequency And MagnitudeNovember 5, 2024 | seekingalpha.comGetinge AB (publ) (OTCMKTS:GNGBY) Stock Crosses Below Fifty Day Moving Average - What's Next?Getinge AB (publ) (OTCMKTS:GNGBY) Share Price Crosses Below 50 Day Moving Average - Time to Sell?October 30, 2024 | marketbeat.comGetinge price target lowered to SEK 180 from SEK 190 at JPMorganOctober 23, 2024 | markets.businessinsider.comKepler Capital Reaffirms Their Hold Rating on Getinge (0GZV)October 20, 2024 | markets.businessinsider.comGetinge AB (publ) (OTCMKTS:GNGBY) Short Interest UpdateGetinge AB (publ) (OTCMKTS:GNGBY - Get Free Report) was the recipient of a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 11,300 shares, a decline of 14.4% from the August 15th total of 13,200 shares. Based on an average trading volume of 14,800 shares, the days-to-cover ratio is currently 0.8 days.September 18, 2024 | marketbeat.comGetinge completes Paragonix Technologies acquisitionSeptember 13, 2024 | msn.comParagonix Technologies Signs Definitive Agreement to be Acquired by GetingeAugust 23, 2024 | businesswire.comGetinge AB (publ) (OTCMKTS:GNGBY) Short Interest Up 469.0% in JulyGetinge AB (publ) (OTCMKTS:GNGBY - Get Free Report) was the target of a large increase in short interest in the month of July. As of July 31st, there was short interest totalling 33,000 shares, an increase of 469.0% from the July 15th total of 5,800 shares. Based on an average trading volume of 25,300 shares, the short-interest ratio is presently 1.3 days.August 12, 2024 | marketbeat.comProtean Funds Scandinavia AB July 2024 Partner LetterAugust 6, 2024 | seekingalpha.comShort Interest in Getinge AB (publ) (OTCMKTS:GNGBY) Expands By 56.8%Getinge AB (publ) (OTCMKTS:GNGBY - Get Free Report) was the target of a significant growth in short interest during the month of July. As of July 15th, there was short interest totalling 5,800 shares, a growth of 56.8% from the June 30th total of 3,700 shares. Based on an average daily trading volume, of 47,000 shares, the short-interest ratio is presently 0.1 days.July 27, 2024 | marketbeat.comGetinge (0GZV) Receives a Hold from Kepler CapitalJuly 20, 2024 | markets.businessinsider.comGNGBY Getinge AB ADRMay 23, 2024 | seekingalpha.comGetinge Shares Sink After It Limits Sales of Heart DevicesMay 15, 2024 | marketwatch.comGetinge limits sale of heart devices in the US after FDA warningMay 15, 2024 | reuters.comGetinge Shares Sink After FDA Warns on Heart DevicesMay 10, 2024 | marketwatch.comUS FDA advises healthcare facilities to switch from Getinge's heart devicesMay 8, 2024 | reuters.comUPDATE 2-US FDA advises healthcare facilities to switch from Getinge's heart devicesMay 8, 2024 | finance.yahoo.comGNGBF Getinge AB (publ)April 28, 2024 | seekingalpha.comGetinge AB (GNGBF) Q1 2024 Earnings Call TranscriptApril 24, 2024 | seekingalpha.comGetinge AB's Dividend AnalysisApril 22, 2024 | finance.yahoo.comHere's what to expect from Getinge AB's earningsApril 21, 2024 | markets.businessinsider.comGetinge takes a leap forward in cardiovascular surgery with the 510(k) clearance for Vasoview Hemopro 3March 8, 2024 | finance.yahoo.comGetinge AB Series BMarch 1, 2024 | wsj.comGetinge AB (publ) (OTCMKTS:GNGBY) Short Interest Up 31.1% in DecemberGetinge AB (publ) (OTCMKTS:GNGBY - Get Free Report) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 5,900 shares, an increase of 31.1% from the November 30th total of 4,500 shares. Based on an average daily volume of 7,500 shares, the days-to-cover ratio is currently 0.8 days.December 31, 2023 | marketbeat.comGetinge AB (publ) (GNGBY)December 17, 2023 | finance.yahoo.comGetinge AB ADR GNGBYNovember 5, 2023 | morningstar.comGetinge AB (publ) Non-GAAP EPS of $2.66, revenue of $7.61B beats by $6.94BOctober 23, 2023 | msn.comUPDATE 1-Middle East conflict weighs on European stocks at start of busy weekOctober 23, 2023 | finance.yahoo.comGetinge acquires Healthmark Industries Co. Inc.October 11, 2023 | finance.yahoo.comGetinge AB (publ) (OTCMKTS:GNGBY) Receives Consensus Recommendation of "Hold" from AnalystsGetinge AB (publ) (OTCMKTS:GNGBY - Get Free Report) has earned an average recommendation of "Hold" from the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and twoSeptember 22, 2023 | marketbeat.comGetinge AB (publ) (OTCMKTS:GNGBY) Given Consensus Recommendation of "Hold" by BrokeragesGetinge AB (publ) (OTCMKTS:GNGBY - Get Free Report) has received a consensus rating of "Hold" from the six research firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation andAugust 28, 2023 | marketbeat.comGetinge AB (publ) (OTCMKTS:GNGBY) Sees Significant Increase in Short InterestGetinge AB (publ) (OTCMKTS:GNGBY - Get Free Report) was the recipient of a significant growth in short interest in August. As of August 15th, there was short interest totalling 19,200 shares, a growth of 734.8% from the July 31st total of 2,300 shares. Based on an average daily volume of 55,000 shares, the days-to-cover ratio is presently 0.3 days.August 25, 2023 | marketbeat.comGetinge AB (publ) (OTCMKTS:GNGBY) Short Interest Down 84.2% in JuneGetinge AB (publ) (OTCMKTS:GNGBY - Get Free Report) was the target of a significant drop in short interest during the month of June. As of June 30th, there was short interest totalling 600 shares, a drop of 84.2% from the June 15th total of 3,800 shares. Based on an average daily trading volume, of 65,400 shares, the short-interest ratio is currently 0.0 days.July 14, 2023 | marketbeat.comGetinge AB (publ) (OTCMKTS:GNGBY) Given Average Recommendation of "Hold" by AnalystsGetinge AB (publ) (OTCMKTS:GNGBY - Free Report) has received a consensus recommendation of "Hold" from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendaJuly 9, 2023 | marketbeat.comGetinge AB (publ) (OTCMKTS:GNGBY) Cut to Equal Weight at Morgan StanleyMorgan Stanley lowered shares of Getinge AB (publ) from an "overweight" rating to an "equal weight" rating in a research report on Friday.July 7, 2023 | marketbeat.comGetinge AB (publ) (OTCMKTS:GNGBY) Sees Significant Growth in Short InterestGetinge AB (publ) (OTCMKTS:GNGBY - Free Report) saw a significant growth in short interest in June. As of June 15th, there was short interest totalling 3,800 shares, a growth of 192.3% from the May 31st total of 1,300 shares. Based on an average daily volume of 20,100 shares, the short-interest ratio is presently 0.2 days.June 30, 2023 | marketbeat.comGetinge AB (publ) (OTCMKTS:GNGBY) Rating Lowered to Hold at DNB MarketsDNB Markets lowered Getinge AB (publ) from a "buy" rating to a "hold" rating in a report on Tuesday.June 20, 2023 | marketbeat.comGetinge AB (publ) (OTCMKTS:GNGBY) Receives Average Recommendation of "Hold" from AnalystsGetinge AB (publ) (OTCMKTS:GNGBY - Get Rating) has been given an average rating of "Hold" by the six ratings firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and threJune 14, 2023 | marketbeat.comGetinge to acquire High Purity New England, Inc., a leading provider of single-use solutions for bioprocessing applicationsMay 31, 2023 | finance.yahoo.comGetinge AB (publ) (OTCMKTS:GNGBY) Receives Consensus Recommendation of "Hold" from BrokeragesShares of Getinge AB (publ) (OTCMKTS:GNGBY - Get Rating) have been assigned an average recommendation of "Hold" from the eight ratings firms that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, five have given a hold rating and two have iApril 25, 2023 | marketbeat.comGetinge AB (publ) Plans Dividend of $0.29 (OTCMKTS:GNGBY)Getinge AB (publ) (OTCMKTS:GNGBY) declared a dividend on Friday, April 21st. Shareholders of record on Friday, April 28th will be given a dividend of 0.2922 per share on Friday, May 19th. This represents a yield of 1.16%. The ex-dividend date is Thursday, April 27th.April 21, 2023 | marketbeat.comGetinge AB (publ) (OTCMKTS:GNGBY) Short Interest Up 2,500.0% in MarchGetinge AB (publ) (OTCMKTS:GNGBY - Get Rating) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 2,600 shares, an increase of 2,500.0% from the March 15th total of 100 shares. Based on an average daily trading volume, of 14,700 shares, the days-to-cover ratio is currently 0.2 days.April 14, 2023 | marketbeat.comUS FDA identifies recall of Getinge's heart devices as most seriousMarch 31, 2023 | finance.yahoo.comGetinge AB (publ) (OTCMKTS:GNGBY) Receives Average Rating of "Hold" from AnalystsShares of Getinge AB (publ) (OTCMKTS:GNGBY - Get Rating) have been assigned an average recommendation of "Hold" from the seven brokerages that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, four have given a hold ratinMarch 31, 2023 | marketbeat.comGetinge recieves FDA premarket approval for the iCast™ covered stent system in the USMarch 24, 2023 | finance.yahoo.comUS FDA classifies recall of heart devices by Getinge as most seriousMarch 17, 2023 | finance.yahoo.comGetinge AB (publ) (OTCMKTS:GNGBY) Receives Consensus Rating of "Hold" from AnalystsShares of Getinge AB (publ) (OTCMKTS:GNGBY - Get Rating) have earned a consensus recommendation of "Hold" from the eight ratings firms that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, five have issued a holMarch 6, 2023 | marketbeat.comGetinge AB (publ) (OTCMKTS:GNGBY) Short Interest Up 300.0% in JanuaryGetinge AB (publ) (OTCMKTS:GNGBY - Get Rating) saw a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 2,800 shares, a growth of 300.0% from the January 15th total of 700 shares. Based on an average trading volume of 21,300 shares, the days-to-cover ratio is currently 0.1 days.February 10, 2023 | marketbeat.comGetinge AB (publ) (OTCMKTS:GNGBY) Given Consensus Rating of "Hold" by AnalystsShares of Getinge AB (publ) (OTCMKTS:GNGBY - Get Rating) have earned a consensus recommendation of "Hold" from the eight research firms that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, five have given a hold ratingFebruary 9, 2023 | marketbeat.comFDA classifies recall of Getinge's heart devices as most seriousJanuary 27, 2023 | reuters.com Get Getinge AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for GNGBY and its competitors with MarketBeat's FREE daily newsletter. Email Address $2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth. Click here to see his new research now. GNGBY Media Mentions By Week GNGBY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNGBY News Sentiment▼0.000.60▲Average Medical News Sentiment GNGBY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNGBY Articles This Week▼00▲GNGBY Articles Average Week Get Getinge AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for GNGBY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MASI News ITGR News LIVN News CNMD News TMDX News SLNO News INMD News BLFS News CBLL News AXGN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:GNGBY) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Getinge AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Getinge AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
